Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies
Clinical trial NCT00477035 · COMPLETED
Trial details
- NCT number
- NCT00477035
- Sponsor
- Sally Arai
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2011-03-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.